MODALTIN

Serial Number 88196892
606

Registration Progress

Application Filed
Nov 16, 2018
Under Examination
May 28, 2019
Approved for Publication
Apr 2, 2019
Published for Opposition
Apr 2, 2019
Registered

Trademark Image

MODALTIN

Basic Information

Serial Number
88196892
Filing Date
November 16, 2018
Published for Opposition
April 2, 2019
Abandonment Date
July 4, 2022
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 4, 2022
Classes
005

Rights Holder

Tonix Pharmaceuticals, Inc.

03
Address
509 Madison Avenue, Suite 306
New York, NY 10022

Ownership History

Tonix Pharmaceuticals, Inc.

Original Applicant
03
New York, NY

Tonix Pharmaceuticals, Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Francis J. Duffin

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

36 events
Date Code Type Description Documents
Jul 5, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jul 4, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Feb 19, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 18, 2022 EX5G S SOU EXTENSION 5 GRANTED Loading...
Feb 8, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jan 5, 2022 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Jan 5, 2022 PETG O PETITION TO REVIVE-GRANTED Loading...
Jan 5, 2022 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION Loading...
Jan 5, 2022 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Jan 3, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jan 3, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Nov 28, 2021 EXT5 S SOU EXTENSION 5 FILED Loading...
May 15, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 13, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 13, 2021 EXT4 S SOU EXTENSION 4 FILED Loading...
May 13, 2021 EX4G S SOU EXTENSION 4 GRANTED Loading...
Oct 31, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 29, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 29, 2020 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 29, 2020 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 2, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 30, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 30, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 30, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
Nov 27, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 25, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 25, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 25, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 28, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 2, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 2, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 13, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 21, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 21, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 4, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 20, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of sleep disorders, fibromyalgia, post-traumatic stress disorder, functional somatic disorder, addiction, alcoholism, disorders of the nervous system, disorders of the musculo-skeletal system, disorders of the endocrine system, disorders of the musculoskeletal system, neurological disorders, hormonal disorder, psychiatric related diseases and disorders
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005